Phosphoinositide 3-Kinase (PI3K) Inhibitors
PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellula ... Read More
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global In-vitro Toxicity Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Static Well Plate System 1.2.3 Multi-compartmental Perfused Systems 1.3 Market by Application 1.3.1 Global In-vitro Toxicity Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Pharmaceutical and Biotechnology Companies 1.3.3 Academic and Research Institutions 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global In-vitro Toxicity Testing Market Perspective (2016-2027) 2.2 In-vitro Toxicity Testing Growth Trends by Regions 2.2.1 In-vitro Toxicity Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 In-vitro Toxicity Testing Historic Market Share by Regions (2016-2021) 2.2.3 In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027) 2.3 In-vitro Toxicity Testing Industry Dynamic 2.3.1 In-vitro Toxicity Testing Market Trends 2.3.2 In-vitro Toxicity Testing Market Drivers 2.3.3 In-vitro Toxicity Testing Market Challenges 2.3.4 In-vitro Toxicity Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top In-vitro Toxicity Testing Players by Revenue 3.1.1 Global Top In-vitro Toxicity Testing Players by Revenue (2016-2021) 3.1.2 Global In-vitro Toxicity Testing Revenue Market Share by Players (2016-2021) 3.2 Global In-vitro Toxicity Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by In-vitro Toxicity Testing Revenue 3.4 Global In-vitro Toxicity Testing Market Concentration Ratio 3.4.1 Global In-vitro Toxicity Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by In-vitro Toxicity Testing Revenue in 2020 3.5 In-vitro Toxicity Testing Key Players Head office and Area Served 3.6 Key Players In-vitro Toxicity Testing Product Solution and Service 3.7 Date of Enter into In-vitro Toxicity Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 In-vitro Toxicity Testing Breakdown Data by Type 4.1 Global In-vitro Toxicity Testing Historic Market Size by Type (2016-2021) 4.2 Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027) 5 In-vitro Toxicity Testing Breakdown Data by Application 5.1 Global In-vitro Toxicity Testing Historic Market Size by Application (2016-2021) 5.2 Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America In-vitro Toxicity Testing Market Size (2016-2027) 6.2 North America In-vitro Toxicity Testing Market Size by Type 6.2.1 North America In-vitro Toxicity Testing Market Size by Type (2016-2021) 6.2.2 North America In-vitro Toxicity Testing Market Size by Type (2022-2027) 6.2.3 North America In-vitro Toxicity Testing Market Size by Type (2016-2027) 6.3 North America In-vitro Toxicity Testing Market Size by Application 6.3.1 North America In-vitro Toxicity Testing Market Size by Application (2016-2021) 6.3.2 North America In-vitro Toxicity Testing Market Size by Application (2022-2027) 6.3.3 North America In-vitro Toxicity Testing Market Size by Application (2016-2027) 6.4 North America In-vitro Toxicity Testing Market Size by Country 6.4.1 North America In-vitro Toxicity Testing Market Size by Country (2016-2021) 6.4.2 North America In-vitro Toxicity Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe In-vitro Toxicity Testing Market Size (2016-2027) 7.2 Europe In-vitro Toxicity Testing Market Size by Type 7.2.1 Europe In-vitro Toxicity Testing Market Size by Type (2016-2021) 7.2.2 Europe In-vitro Toxicity Testing Market Size by Type (2022-2027) 7.2.3 Europe In-vitro Toxicity Testing Market Size by Type (2016-2027) 7.3 Europe In-vitro Toxicity Testing Market Size by Application 7.3.1 Europe In-vitro Toxicity Testing Market Size by Application (2016-2021) 7.3.2 Europe In-vitro Toxicity Testing Market Size by Application (2022-2027) 7.3.3 Europe In-vitro Toxicity Testing Market Size by Application (2016-2027) 7.4 Europe In-vitro Toxicity Testing Market Size by Country 7.4.1 Europe In-vitro Toxicity Testing Market Size by Country (2016-2021) 7.4.2 Europe In-vitro Toxicity Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific In-vitro Toxicity Testing Market Size (2016-2027) 8.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type 8.2.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application 8.3.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific In-vitro Toxicity Testing Market Size by Region 8.4.1 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America In-vitro Toxicity Testing Market Size (2016-2027) 9.2 Latin America In-vitro Toxicity Testing Market Size by Type 9.2.1 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021) 9.2.2 Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027) 9.2.3 Latin America In-vitro Toxicity Testing Market Size by Type (2016-2027) 9.3 Latin America In-vitro Toxicity Testing Market Size by Application 9.3.1 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021) 9.3.2 Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027) 9.3.3 Latin America In-vitro Toxicity Testing Market Size by Application (2016-2027) 9.4 Latin America In-vitro Toxicity Testing Market Size by Country 9.4.1 Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021) 9.4.2 Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa In-vitro Toxicity Testing Market Size (2016-2027) 10.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type 10.2.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application 10.3.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa In-vitro Toxicity Testing Market Size by Country 10.4.1 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abbott Laboratories 11.1.1 Abbott Laboratories Company Details 11.1.2 Abbott Laboratories Business Overview 11.1.3 Abbott Laboratories In-vitro Toxicity Testing Introduction 11.1.4 Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.1.5 Abbott Laboratories Recent Development 11.2 Agilent Technologies Inc. 11.2.1 Agilent Technologies Inc. Company Details 11.2.2 Agilent Technologies Inc. Business Overview 11.2.3 Agilent Technologies Inc. In-vitro Toxicity Testing Introduction 11.2.4 Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.2.5 Agilent Technologies Inc. Recent Development 11.3 Bio-Rad Laboratories Inc. 11.3.1 Bio-Rad Laboratories Inc. Company Details 11.3.2 Bio-Rad Laboratories Inc. Business Overview 11.3.3 Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Introduction 11.3.4 Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.3.5 Bio-Rad Laboratories Inc. Recent Development 11.4 CELTHER POLSKA Sp z o.o. 11.4.1 CELTHER POLSKA Sp z o.o. Company Details 11.4.2 CELTHER POLSKA Sp z o.o. Business Overview 11.4.3 CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Introduction 11.4.4 CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.4.5 CELTHER POLSKA Sp z o.o. Recent Development 11.5 Charles River Laboratories International Inc. 11.5.1 Charles River Laboratories International Inc. Company Details 11.5.2 Charles River Laboratories International Inc. Business Overview 11.5.3 Charles River Laboratories International Inc. In-vitro Toxicity Testing Introduction 11.5.4 Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.5.5 Charles River Laboratories International Inc. Recent Development 11.6 Eurofins GSC Lux Sarl 11.6.1 Eurofins GSC Lux Sarl Company Details 11.6.2 Eurofins GSC Lux Sarl Business Overview 11.6.3 Eurofins GSC Lux Sarl In-vitro Toxicity Testing Introduction 11.6.4 Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.6.5 Eurofins GSC Lux Sarl Recent Development 11.7 Evotec AG 11.7.1 Evotec AG Company Details 11.7.2 Evotec AG Business Overview 11.7.3 Evotec AG In-vitro Toxicity Testing Introduction 11.7.4 Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.7.5 Evotec AG Recent Development 11.8 General Electric Co. 11.8.1 General Electric Co. Company Details 11.8.2 General Electric Co. Business Overview 11.8.3 General Electric Co. In-vitro Toxicity Testing Introduction 11.8.4 General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.8.5 General Electric Co. Recent Development 11.9 Merck KGaA 11.9.1 Merck KGaA Company Details 11.9.2 Merck KGaA Business Overview 11.9.3 Merck KGaA In-vitro Toxicity Testing Introduction 11.9.4 Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.9.5 Merck KGaA Recent Development 11.10 Thermo Fisher Scientific Inc. 11.10.1 Thermo Fisher Scientific Inc. Company Details 11.10.2 Thermo Fisher Scientific Inc. Business Overview 11.10.3 Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Introduction 11.10.4 Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) 11.10.5 Thermo Fisher Scientific Inc. Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details
List of Tables Table 1. Global In-vitro Toxicity Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Static Well Plate System Table 3. Key Players of Multi-compartmental Perfused Systems Table 4. Global In-vitro Toxicity Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 5. Global In-vitro Toxicity Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global In-vitro Toxicity Testing Market Size by Regions (2016-2021) & (US$ Million) Table 7. Global In-vitro Toxicity Testing Market Share by Regions (2016-2021) Table 8. Global In-vitro Toxicity Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 9. Global In-vitro Toxicity Testing Market Share by Regions (2022-2027) Table 10. In-vitro Toxicity Testing Market Trends Table 11. In-vitro Toxicity Testing Market Drivers Table 12. In-vitro Toxicity Testing Market Challenges Table 13. In-vitro Toxicity Testing Market Restraints Table 14. Global In-vitro Toxicity Testing Revenue by Players (2016-2021) & (US$ Million) Table 15. Global In-vitro Toxicity Testing Market Share by Players (2016-2021) Table 16. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2020) Table 17. Ranking of Global Top In-vitro Toxicity Testing Companies by Revenue (US$ Million) in 2020 Table 18. Global 5 Largest Players Market Share by In-vitro Toxicity Testing Revenue (CR5 and HHI) & (2016-2021) Table 19. Key Players Headquarters and Area Served Table 20. Key Players In-vitro Toxicity Testing Product Solution and Service Table 21. Date of Enter into In-vitro Toxicity Testing Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 24. Global In-vitro Toxicity Testing Revenue Market Share by Type (2016-2021) Table 25. Global In-vitro Toxicity Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 26. Global In-vitro Toxicity Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 27. Global In-vitro Toxicity Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 28. Global In-vitro Toxicity Testing Revenue Market Share by Application (2016-2021) Table 29. Global In-vitro Toxicity Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 30. Global In-vitro Toxicity Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 31. North America In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 32. North America In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million) Table 33. North America In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million) Table 34. North America In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million) Table 35. North America In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) Table 36. North America In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) Table 37. Europe In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 38. Europe In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million) Table 39. Europe In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million) Table 40. Europe In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million) Table 41. Europe In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) Table 42. Europe In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) Table 43. Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 44. Asia-Pacific In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million) Table 45. Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million) Table 46. Asia-Pacific In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million) Table 47. Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2016-2021) & (US$ Million) Table 48. Asia-Pacific In-vitro Toxicity Testing Market Size by Region (2022-2027) & (US$ Million) Table 49. Latin America In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 50. Latin America In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million) Table 51. Latin America In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million) Table 52. Latin America In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million) Table 53. Latin America In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) Table 54. Latin America In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) Table 55. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2016-2021) (US$ Million) Table 56. Middle East & Africa In-vitro Toxicity Testing Market Size by Type (2022-2027) & (US$ Million) Table 57. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2016-2021) (US$ Million) Table 58. Middle East & Africa In-vitro Toxicity Testing Market Size by Application (2022-2027) & (US$ Million) Table 59. Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2016-2021) & (US$ Million) Table 60. Middle East & Africa In-vitro Toxicity Testing Market Size by Country (2022-2027) & (US$ Million) Table 61. Abbott Laboratories Company Details Table 62. Abbott Laboratories Business Overview Table 63. Abbott Laboratories In-vitro Toxicity Testing Product Table 64. Abbott Laboratories Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 65. Abbott Laboratories Recent Development Table 66. Agilent Technologies Inc. Company Details Table 67. Agilent Technologies Inc. Business Overview Table 68. Agilent Technologies Inc. In-vitro Toxicity Testing Product Table 69. Agilent Technologies Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 70. Agilent Technologies Inc. Recent Development Table 71. Bio-Rad Laboratories Inc. Company Details Table 72. Bio-Rad Laboratories Inc. Business Overview Table 73. Bio-Rad Laboratories Inc. In-vitro Toxicity Testing Product Table 74. Bio-Rad Laboratories Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 75. Bio-Rad Laboratories Inc. Recent Development Table 76. CELTHER POLSKA Sp z o.o. Company Details Table 77. CELTHER POLSKA Sp z o.o. Business Overview Table 78. CELTHER POLSKA Sp z o.o. In-vitro Toxicity Testing Product Table 79. CELTHER POLSKA Sp z o.o. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 80. CELTHER POLSKA Sp z o.o. Recent Development Table 81. Charles River Laboratories International Inc. Company Details Table 82. Charles River Laboratories International Inc. Business Overview Table 83. Charles River Laboratories International Inc. In-vitro Toxicity Testing Product Table 84. Charles River Laboratories International Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 85. Charles River Laboratories International Inc. Recent Development Table 86. Eurofins GSC Lux Sarl Company Details Table 87. Eurofins GSC Lux Sarl Business Overview Table 88. Eurofins GSC Lux Sarl In-vitro Toxicity Testing Product Table 89. Eurofins GSC Lux Sarl Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 90. Eurofins GSC Lux Sarl Recent Development Table 91. Evotec AG Company Details Table 92. Evotec AG Business Overview Table 93. Evotec AG In-vitro Toxicity Testing Product Table 94. Evotec AG Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 95. Evotec AG Recent Development Table 96. General Electric Co. Company Details Table 97. General Electric Co. Business Overview Table 98. General Electric Co. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 99. General Electric Co. Recent Development Table 100. Merck KGaA Company Details Table 101. Merck KGaA Business Overview Table 102. Merck KGaA In-vitro Toxicity Testing Product Table 103. Merck KGaA Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 104. Merck KGaA Recent Development Table 105. Thermo Fisher Scientific Inc. Company Details Table 106. Thermo Fisher Scientific Inc. Business Overview Table 107. Thermo Fisher Scientific Inc. In-vitro Toxicity Testing Product Table 108. Thermo Fisher Scientific Inc. Revenue in In-vitro Toxicity Testing Business (2016-2021) & (US$ Million) Table 109. Thermo Fisher Scientific Inc. Recent Development Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Global In-vitro Toxicity Testing Market Share by Type: 2020 VS 2027 Figure 2. Static Well Plate System Features Figure 3. Multi-compartmental Perfused Systems Features Figure 4. Global In-vitro Toxicity Testing Market Share by Application: 2020 VS 2027 Figure 5. Pharmaceutical and Biotechnology Companies Case Studies Figure 6. Academic and Research Institutions Case Studies Figure 7. Others Case Studies Figure 8. In-vitro Toxicity Testing Report Years Considered Figure 9. Global In-vitro Toxicity Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global In-vitro Toxicity Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global In-vitro Toxicity Testing Market Share by Regions: 2020 VS 2027 Figure 12. Global In-vitro Toxicity Testing Market Share by Regions (2022-2027) Figure 13. Global In-vitro Toxicity Testing Market Share by Players in 2020 Figure 14. Global Top In-vitro Toxicity Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-vitro Toxicity Testing as of 2020 Figure 15. The Top 10 and 5 Players Market Share by In-vitro Toxicity Testing Revenue in 2020 Figure 16. Global In-vitro Toxicity Testing Revenue Market Share by Type (2016-2021) Figure 17. Global In-vitro Toxicity Testing Revenue Market Share by Type (2022-2027) Figure 18. North America In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America In-vitro Toxicity Testing Market Share by Type (2016-2027) Figure 20. North America In-vitro Toxicity Testing Market Share by Application (2016-2027) Figure 21. North America In-vitro Toxicity Testing Market Share by Country (2016-2027) Figure 22. United States In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe In-vitro Toxicity Testing Market Share by Type (2016-2027) Figure 26. Europe In-vitro Toxicity Testing Market Share by Application (2016-2027) Figure 27. Europe In-vitro Toxicity Testing Market Share by Country (2016-2027) Figure 28. Germany In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific In-vitro Toxicity Testing Market Share by Type (2016-2027) Figure 36. Asia-Pacific In-vitro Toxicity Testing Market Share by Application (2016-2027) Figure 37. Asia-Pacific In-vitro Toxicity Testing Market Share by Region (2016-2027) Figure 38. China In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America In-vitro Toxicity Testing Market Share by Type (2016-2027) Figure 46. Latin America In-vitro Toxicity Testing Market Share by Application (2016-2027) Figure 47. Latin America In-vitro Toxicity Testing Market Share by Country (2016-2027) Figure 48. Mexico In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa In-vitro Toxicity Testing Market Share by Type (2016-2027) Figure 52. Middle East & Africa In-vitro Toxicity Testing Market Share by Application (2016-2027) Figure 53. Middle East & Africa In-vitro Toxicity Testing Market Share by Country (2016-2027) Figure 54. Turkey In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE In-vitro Toxicity Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Abbott Laboratories Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 58. Agilent Technologies Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 59. Bio-Rad Laboratories Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 60. CELTHER POLSKA Sp z o.o. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 61. Charles River Laboratories International Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 62. Eurofins GSC Lux Sarl Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 63. Evotec AG Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 64. General Electric Co. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 65. Merck KGaA Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 66. Thermo Fisher Scientific Inc. Revenue Growth Rate in In-vitro Toxicity Testing Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed
Abbott Laboratories Agilent Technologies Inc. Bio-Rad Laboratories Inc. CELTHER POLSKA Sp z o.o. Charles River Laboratories International Inc. Eurofins GSC Lux Sarl Evotec AG General Electric Co. Merck KGaA Thermo Fisher Scientific Inc.
PI3K inhibitors work by inhibiting PI3K enzymes, which helps in signaling the pathway for cellula ... Read More
The central nervous system (CNS) is the part of the nervous system consisting of the brain ... Read More
The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein th ... Read More
Solar home systems (SHS) are stand-alone photovoltaic systems that offer a cost-effective mode of ... Read More